Acta Biomedica Scientifica (May 2012)

ANTIBODIES TO BENZO[A]PYRENE IN SERUM OF PATIENTS WITH NON-SMALL CELL LUNG CANCER

  • E. G. Polenok,
  • T. P. Anosova,
  • M. P. Anosov,
  • K. S. Krasilnikova,
  • E. A. Gurov,
  • V. A. Titov,
  • N. E. Verzhbitskaja,
  • I. A. Vafin,
  • S. E. Ragozhina,
  • A. N. Glushkov

Journal volume & issue
Vol. 0, no. 3(2)
pp. 151 – 154

Abstract

Read online

The features of immune response to chemical carcinogen benzo[a]pyrene (Bp) at the patients with non-small cell lung cancer (NSCLC) are investigated. The isotypical distinctions in formation of antibodies (Ab) to Bp at the men with NSCLC in comparison with healthy are revealed. There were more often observed the high levels of IgG Ab-Bp at the men with NSCLC. Thus risk of occurrence NSCLC grows almost in 2 times at high levels of Ab-Bp of a class G.

Keywords